TABLE 1

Pre- and Postoperative Patient Characteristics

CharacteristicPatient 1Patient 2Patient 3Patient 4Patient 5Patient 6
 Age (y)595773727356
 Initial PSA level (ng/mL)111.15.727.030.69.676.3
Prostate biopsy
 Gleason score4 + 3 = 7b3 + 4 = 7a3 + 4 = 7a4 + 3 = 7b3 + 4 = 7a8
 Cancer locationR < LR > LR = LL onlyR > LR = L
 Number of positive cores6/105/85/63/127/1011/11
 Clinical stagecT2c (L lobe)cT2a (R base)cT1cT1cT2c (bilateral)cT2c (both lobes)
 TRUS suggestive of cancerL lobeR baseNormalNormalR baseBoth lobes
 TRUS prostate volume (cm3)364036391749
Staging
 Bone scan indicationNot done (PSMA PET)Routine scanPSA elevationNot done (PSMA PET)Routine scanNot done (PSMA PET)
 Bone scan resultL os ilium lesionExclusion of metsL3 lesion
68Ga-PSMA PET indicationExclusion of metsSuggestive bone scanExclusion of metsExclusion of metsExclusion of metsExclusion of mets
68Ga-PSMA PET resultParailiac LN metsEquivocal*No lesionsNo lesionsNo lesionsLN mets
RPE
 Prostate volume (cm3)483440523051
 Cancer volume (cm3)20.92.65.714.57.830.2
 Cancer involvement43.5%7.8%14.6%27.9%26.5%59.2%
 Gleason score4 + 3 = 7b3 + 4 = 7a4 + 3 = 7b4 + 3 = 7b4 + 5 = 9a4 + 5 = 9a
 Positive surgical marginL apexNoR anteriorL seminal vesicleNoL posterior
 Seminal vesicle invasionBothLNoLBothBoth
 Pathologic stagepT3b pN1pT3b pN0pT3a pN0pT3b pN1pT3b pN0pT3b N1
  • * Possible bony lesion.

  • Iliac, aortal, and pararectal.

  • PSA = prostate-specific antigen; TRUS = transrectal ultrasound; mets = metastasis; LN = lymph node.